KATRINA MOTLEY: Open Payments
NPI 1174934780 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,570 in 221 payments from 20 companies in 2025. Trend: 2023 $4,079 · 2024 $4,496 · 2025 $5,570
Food & beverage: $5,358Education: $211
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 39 | $1,077 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $568 |
| E.R. Squibb & Sons, L.L.C. | 18 | $535 |
| Otsuka America Pharmaceutical, Inc. | 28 | $527 |
| Vanda Pharmaceuticals Inc. | 16 | $403 |
| Janssen Pharmaceuticals, Inc | 13 | $397 |
| JAZZ PHARMACEUTICALS INC. | 13 | $332 |
| Alkermes, Inc. | 20 | $329 |
| Axsome Therapeutics, Inc. | 6 | $327 |
| Neurocrine BioSciences, Inc. | 7 | $243 |
Products named: AUSTEDO XR, CAPLYTA, COBENFY, REXULTI, HETLIOZ, INVEGA SUSTENNA, EPIDIOLEX, Auvelity.
Industry payments across IN — which companies pay providers there.
